Andrew Burgess

Andrew Burgess is a highly qualified professional with a diverse educational background. He holds a PhD in Cell Cycle and Cancer, a BSc Honours 1st Class in Toxicology, and a BSc in Physiology and Pharmacology from The University of Queensland.

Andrew has held various key positions in prestigious organizations, showcasing his extensive experience and expertise in the field. Currently, he serves as the Head of the Cell Division Lab at The ANZAC Research Institute. Previously, he has been an Associate Professor at the University of Sydney and a Senior Hospital Scientist at The ANZAC Research Institute, demonstrating his strong background in research and academia.

In addition to his current role, Andrew Burgess has had a rich and varied career history. He has served as a Director at ASMR, a Conjoint Senior Lecturer at St Vincent's Clinical School - University of NSW, and the University of New South Wales. Furthermore, he has held positions such as Group Leader at Garvan Institute of Medical Research and Senior Postdoctoral Researcher at CRBM - CNRS UMR 5237, highlighting his wide-ranging expertise and leadership capabilities in the scientific community.

Andrew's research journey also includes roles such as FRM Postdoctoral Fellow, La Ligue Postdoctoral Fellow, and CJ Martin Postdoctoral Fellow at CRBM - CNRS UMR 5237. Moreover, he has contributed to research efforts as a Postdoctoral Researcher at Diamantina Institute and as a Research Assistant at Queensland Institute of Medical Research, showcasing his dedication and commitment to advancing scientific knowledge.

Overall, Andrew Burgess stands out as a distinguished professional with a strong educational foundation and a wealth of experience in various scientific roles. His contributions to the field of Cell Cycle and Cancer research have been significant, making him a respected figure in the academic and research community.